Arquivos do dia: Outubro 29, 2021
A efetividade da vacina da AstraZeneca em idosos durante a circulação da variante gama do SARS-CoV-2 em São Paulo foi de 77,9% contra Covid-19 sintomática, 87,6% contra internação e 93,6% contra morte.
29 Out, 2021 | 14:59h
Comentário no Twitter (fio – clique para saber mais)
Effectiveness of Oxford-AstraZeneca COVID-19 vaccine by dose in over 60s in São Paulo state, published today in @NatureComms with @juliocroda @otavio_ranzani @datcummings as part of the VEBRA COVID-19 group 1/8https://t.co/zIbPb45nEJ
— Matt Hitchings (@MHitchingsEpi) October 28, 2021
Atualização sobre as sequelas pós-agudas da infecção por SARS-CoV-2: cuidados clínicos aos portadores de “long Covid”.
29 Out, 2021 | 14:57hConteúdos relacionados:
Systematic Review: Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection.
WHO Consensus: A clinical case definition of post COVID-19 condition (Long Covid).
Characterizing long COVID: a living systematic review.
Long Covid – The illness narratives.
New guidelines to help doctors manage long COVID patients published.
M-A: More than 50 long-term effects of COVID-19. (vários artigos sobre o tema)
Subnotificação de mortes limita a compreensão sobre o verdadeiro impacto da Covid-19.
29 Out, 2021 | 14:54hUnder-reporting of deaths limits our understanding of true burden of covid-19 – The BMJ
Conteúdos relacionados:
Study shows COVID-19 has caused the biggest decrease in life expectancy since World War II.
Just how do deaths due to COVID-19 stack up?
Exploring the gap between excess mortality and COVID-19 deaths in 67 countries.
COVID-19 has caused 6.9 million deaths globally, more than double what official reports show
Comentário no Twitter
Mortality data have been essential in understanding the spread of covid-19 and navigating the trade-offs that underlie political decision making, yet under-reporting in official death records has greatly obscured this understanding.
What should be done?https://t.co/pI8aVpa3NR
— The BMJ (@bmj_latest) October 14, 2021
Vacinas de mRNA induzem memória imunológica durável contra SARS-CoV-2 e variantes de preocupação.
29 Out, 2021 | 14:53hmRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern – Science
Comentário do autor no Twitter (fio – clique para saber mais)
Antibodies come and go, but memory cells are forever (maybe not forever, but at least 6 months). Our latest in @ScienceMagazine: https://t.co/YHHBMrMsTA
How long does immune memory last after #mRNA vax? Is it effective vs. variants? What about “boosted” responses?
Full 🧵⬇️… pic.twitter.com/oZ5BxLuVdw
— Rishi Goel (@rishirajgoel) October 14, 2021
Complicações da COVID-19 crítica: considerações terapêuticas e diagnósticas para o paciente sob ventilação mecânica.
29 Out, 2021 | 14:51h
Nove palavras pandêmicas que poucos acertam como utilizar.
29 Out, 2021 | 14:50hNine Pandemic Words That Almost No One Gets Right – The Atlantic
Diretriz AHA/ACC 2021 para avaliação e diagnóstico de dor torácica.
29 Out, 2021 | 14:49hResumo executivo: 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain – Journal of the American College of Cardiology
Comunicado de imprensa: First-Ever Guideline Focused Solely on Chest Pain Evaluation, Diagnosis Released
Foco da diretriz: Guideline for the Evaluation and Diagnosis of Chest Pain
Pontos principais: 2021 AHA/ACC Chest Pain Guideline – American College of Cardiology
Comentário: New Chest Pain Guidelines Out at Last: Most Tests Have a Role – TCTMD
Comentário no Twitter (fio – clique para saber mais)
The Chest Pain Guidelines are now released!https://t.co/xQxCWzReEN
Top 10: CHEST PAINS
Thanks to the entire writing group and my co-cahirs: Deb Murkerjee & Phil Levy
💥First Chest Pain Guidelines @AHAScience @ACCinTouch pic.twitter.com/s17piamrKR— Dr. Martha Gulati “Get Vaccinated Please” (@DrMarthaGulati) October 28, 2021
Diretriz da OMS para o manejo clínico da exposição ao chumbo.
29 Out, 2021 | 14:46hGuideline for clinical management of exposure to lead – World Health Organization
Resumo executivo: Guideline for clinical management of exposure to lead
Ver também: International Lead Poisoning Prevention Week 2021
Comentário no Twitter (fio – clique para saber mais)
It's International Lead Poisoning Prevention Week
Exposure to lead affects human health, especially children's health. There is no safe level of exposure to lead. Even low levels of lead exposure may cause lifelong health problems.
Let's #BanLeadPaint
👉https://t.co/O7NeRcMrW7 pic.twitter.com/mBV13Urf9r
— World Health Organization (WHO) (@WHO) October 24, 2021
Revisão sistemática | Agonistas receptores de GLP-1 e inibidores de SGLT-2 parecem reduzir o risco de morte por doença cardiovascular e morte por qualquer causa em pessoas com diabetes e doença cardiovascular estabelecida.
29 Out, 2021 | 14:44h
Comentário no Twitter
The effects of DPP‐4 inhibitors, GLP‐1 receptor agonists and SGLT‐2 inhibitors for people with #CardiovascularDisease https://t.co/0FwffSCqbC New @CochraneHeart network meta-analysis looks at evidence from 31 studies. #CardiovascularResearch
— The Cochrane Library (@CochraneLibrary) October 27, 2021